baber/WOPTO huggingface dataset:
Patent NZ-525316-A (NZ)
Title: Detergent and disinfectant for initiating the oxidation of organic substances, containing water-soluble permanganate in an alkaline environment where the pH at least than 10
Inventor: THONHAUSER MANFRED
IPC: C11D3/39
Filed: 2001-07-26
Abstract: A cleaning and disinfecting agent is provided in which water-soluble permanganates are used for initiating the oxidation of organic substances in an alkaline solution and, at the same time, a chemical oxidant, preferably a peroxodisulfate, is used that is suited for inducing radical reactions during the catalytic support provided by manganates arising from the supplied permanganate, the radical reactions effecting the oxidation of organic substances. All constituents exist in powder form, whereby a corresponding powder mixture can be rapidly dissolved in water and without leaving residues. This agent thus depicts a highly effective cleaning and disinfecting agent that has universal applications.
Patent NZ-529257-A (NZ)
Title: Tinitus treatment signal source
Inventor: DAVIS PAUL BENJAMIN
IPC: A61F11/00
Filed: 2000-03-17
Abstract: A device for treating auditory disorders such as tinnitus generates a masking signal and uses a signal filter to accentuate frequency components in the signal in a frequency range where the listener has reduced hearing. The device also generates coherent signal components to the listener within the listening range of the listener to ameliorate unpleasant characteristics of the masking signal.
Patent NZ-536447-A (NZ)
Title: Combination of a beta-2 adrenoceptor agonist and an aminosugar and their use for the treatment of immunomodulatory disorders
Inventor: WEIDNER MORTEN SLOTH
IPC: A61P25/00
Filed: 2003-04-22
Abstract: Disclosed are chemical complexes comprising: (i) a beta-2 adrenoceptor agonist, and (ii) an aminosugar selected from the group consisting of glucosamine, mannosamine, a salt and a derivative thereof, wherein the amino group and/or hydroxyl group of the amino sugar is alkylated, arylated, or acylated, and wherein the anomeric 2-, 3-, 4-, or 6- position is sulphated or phosphorylated. The chemical complexes are used in the manufacture of medicaments for the suppression of hypersensitivity and/or inflammatory reaction in a mammal.
Patent NZ-538899-A (NZ)
Title: Stratified press fabric
Inventor: HANSEN ROBERT A
IPC: D21F7/08
Filed: 2003-10-28
Abstract: A stratified press fabric (10) for the press section of a paper-making machine includes a base fabric (30) in the form of an endless loop. A first staple fibre batt material (40) is attached to the outer side of the base fabric by needling. A fine fabric (44) covers the first staple fibre batt material, and a second staple fibre batt material (50) is attached to the fine fabric by needling. The fibres making up the second staple fibre material are finer, that is, of smaller diameter or denier, than the fibres making up the first staple fibre material. The fine fabric substantially prevents the migration of needled coarser fibres of the first staple fibre batt material and finer fibres of the second staple fibre batt therethrough and substantially prevents the intermingling of fibres from the first and second staple fibre batts.
Patent NZ-539031-A (NZ)
Title: Coating, process of preparation and use thereof on wood substrate
Inventor: BENNI STEFANO
IPC: C09D7/12
Filed: 2003-08-07
Abstract: Disclosed is a coating system for application on wood comprising: a first formulation containing: a primer; a wood antioxidant compound (HALS-steric hindered amines); and an ultraviolet ray (UV) absorbing compound (type 3); and a second formulation containing: a finishing coating; a coating antioxidant compound (HALS-steric hindered amines); an ultraviolet ray (UV) absorbing compound (type 1); and an ultraviolet ray (UV) absorbing compound (type 2).
Patent NZ-540500-A (NZ)
Title: Power pole assembly with upper part telescoping in fixed lower part
Inventor: GWYNNE BERNARD
Filed: 2005-06-02
Abstract: An upper part 12 has light 20 and telescopes within a fixed lower part 11 so as to allow maintenance of light 20 from an adjacent walkway 28. A cable 34A is connected to light 20 and to junction box 16.
Patent NZ-541764-A (NZ)
Title: Fire damper with rotary valve, to respond to selected condition to close, with sealing provided in closed position
Inventor: TRUSS JAMES WALTER GEORGE
IPC: F16L55/10
Filed: 2004-02-10
Abstract: A fire damper for sealing a conduit which extends through a concrete slab to prevent fire and toxic gases from passing from one side of the slab to the other, comprises a housing (10) which has a partially spherical rotatable valve (21). The rotatable valve (21) has an internal passageway (12) of substantially the same diameter as an internal diameter of the conduit. The rotatable valve (21) is rotatable within the housing (10) between an open orientation whereby fluid flow through the damper is substantially unimpeded and a closed orientation. The rotatable valve (21) is actuated by a heat detector in the form of two rings (18, 19) of lead alloy located between the housing (10) and the rotatable valve (21). The damper may also include a deformable seal (not shown) disposed between the housing and the rotatable valve.
Patent NZ-542174-A (NZ)
Title: Quality control method for article and oxygen detecting agent for use therein
Inventor: KODAMA RYUICHI
IPC: B65D79/02
Filed: 2004-02-05
Abstract: Disclosed is a quality control method for an article, characterized in that it comprises forming a set of an article and an oxygen detecting agent having a specific sensitivity corresponding to the kind of the article and conditions for quality control, and carrying out the quality control of the article by utilizing the change in the colour of the an oxygen detecting agent caused by the detection of the concentration of the oxygen entering into the oxygen detecting agent by the elapse of a specific period of time corresponding to the kind of the article and conditions for quality control; and an oxygen detecting agent, characterized in that it comprises a main part thereof and a film which seals and covers said main part and has a specific oxygen permeability and/or carbon dioxide permeability corresponding to the kind of the article to be controlled with respect to its quality and conditions for quality control.
Patent NZ-544828-A (NZ)
Title: Use of cardiotrophin to modulate stem cell proliferation
Inventor: MEGENEY LYNN
IPC: C07K14/52
Filed: 2004-06-25
Abstract: Disclosed are methods of promoting stem cell proliferation comprising contacting the cells with cardiotrophin-1 (CT-1). The methods may further comprise contacting the adult stem cells with one or more stem cell modulators that promote differentiation of the stem cells. Methods of inhibiting stem cell proliferation comprising contacting the cells with one or more CT-1 inhibitor are also disclosed.
Patent NZ-550943-A (NZ)
Title: Electric cooking apparatus having removable heating plates and method for using same
Inventor: RAGAN GARY
IPC: A47J9/00
Filed: 2005-05-02
Abstract: A cooking device comprises an upper housing; a lower housing pivotally connected to the upper housing; at least one heating plate removably attached to at least one of the upper housing and the lower housing; and a heating unit disposed in at least one of the upper housing and the lower housing. The heating unit includes a heating element and a heat conducting plate between the heating element and the heating plate. The heat conducting plate conducts heat from the heating element to the heating plate and the heating unit further includes a safety interlock mechanism configured to turn off the heating element when the heating plate is removed from the at least one of the upper housing and the lower housing.
Patent NZ-552983-A (NZ)
Title: Compositions containing nicorandil, preparation method and use
Inventor: NOCENT MATHIEU
IPC: A61K9/20
Filed: 2005-07-05
Abstract: Disclosed is a process for preparing a composition comprising (i) Nicorandil, (ii) a lubricant which is selected from a saturated higher aliphatic acid and its salts and/or a saturated higher alcohol, which is solid at ambient temperature and said lubricant being not micronized, (iii) a disintegrating agent which is sodium croscarmellose, and (iv) a diluent which is mannitol, wherein the process comprises: a first step in which, by weight, 30 parts of Nicorandil, 15 parts of sodium croscarmellose, 35 parts of mannitol and 3 parts of corn starch are mixed so as to form a first pre-mix which is calibrated, a second step in which the calibrated first pre-mix is mixed with 193 parts by weight of mannitol so as to form a second pre-mix, and a third step in which the second pre-mix is mixed with 24 parts by weight of non micronized stearic acid. Also disclosed are compositions obtained by said method, tablets obtained by direct compression, and their use as medicine.
Patent NZ-560468-A (NZ)
Title: Compositions for immunizing against mycobacterium using Ag85A
Inventor: MCSHANE HELEN
IPC: A61K39/04
Filed: 2006-01-05
Abstract: Disclosed is an immunogenic composition comprising a non-replicating or replication impaired poxvirus vector expressing the translation product of a mycobacterial Ag8Sa gene for use in treating or preventing mycobacterial infection or disease by inducing a central memory T cell immune response in a patient, wherein the viral vector expresses Ag8SA with a PK C-terminus tag, a TPA leader sequence, and a truncated C-terminus.
Patent NZ-561842-A (NZ)
Title: Introducing an HRA slurry into a discharge apparatus along with a liquid medium, the slurry not containing organic phosphonate or phosphate
Inventor: WITTBOLD JAMES R
IPC: B01F3/12
Filed: 2005-04-27
Abstract: Disclosed is a method of introducing a heat resistant accelerator (HRA) slurry into a post-mixer aqueous dispersion of calcined gypsum in a discharge apparatus. The method includes: discharging the aqueous dispersion from a second mixing device into a discharge apparatus; and introducing the HRA slurry and a liquid medium from a first mixing device into the discharge apparatus. The HRA slurry comprises a dry-milled HRA with a coating selected from the group consisting of sugar, starch, boric acid, a long chain fatty acid, and a salt of a long chain fatty acid.The HRA slurry does not contain an organic phosphonate or phosphate.
Patent NZ-564014-A (NZ)
Title: Topical pain relief compositions of N,2,3-trimethyl-2-isopropylbutamide (Winsense-23 / WS-23) and methods for using the same
Inventor: SHUDO JUTARO
IPC: C07C233/05
Filed: 2006-10-16
Abstract: Disclosed is a topical pain relief composition which comprises about 15-20% w/w N,2,3-trimethyl-2-isopropylbutamide (also known as Winsense-23 / WS-23) as the only active agent present in said composition, wherein said composition is formulated for application to a keratinized skin site and wherein said composition is not a topical patch preparation or an adhesive gel composition. Further disclosed is use of a topical pain relief composition comprising N,2,3-trimethyl-2-isopropylbutanamide in the preparation of a medicament for treating pain wherein said composition is not a topical patch preparation or an adhesive gel composition.
Patent NZ-572684-A (NZ)
Title: Device and method for detection of a pregnancy associated hormone
Inventor: PLUMMER CHRISTOPHER
IPC: G01N33/558
Filed: 2007-04-20
Abstract: Disclosed is a device (10) for detection of and providing an indication of the concentration of a single pregnancy associated hormone, the device comprising a matrix (16) defining an axial flow path. The matrix comprises of: a sample receiving zone (18) at the upstream end of the flow path for receiving a fluid sample; and a plurality of test zones (22) positioned within the flow path and downstream from the receiving zone. Each test zone is capable of detecting a different concentration of hormone compared with an adjacent test zone. The device also includes an indicator on the device, or on packaging for the device, for recording a previous hormone concentration recorded by the same or a different device.
Patent NZ-575783-A (NZ)
Title: Emulsion
Inventor: FAIYAZIANNASAB FLORA
IPC: A61K8/04
Filed: 2007-09-20
Abstract: Disclosed is an emulsion-type product comprising at least 10 percent (w/w) of a mono alcohol having 2-8 carbon atoms, a water content in the range of 1-6 percent (w/w), a hydrophilic colloid and at least one water immiscible component. Also disclosed is a method for producing an emulsion-type product comprising at least 10 percent (w/w) of a mono alcohol having 2-8 carbon atoms, a water content in the range of 1-6 percent (w/w), a hydrophilic colloid and at least one water immiscible component, said method comprises the steps of: i. Providing a water immiscible phase comprising one or more water immiscible components ii. mixing the at least 10 percent (w/w) mono alcohol having 2-8 carbon atoms with the water in the range of 1-6 percent (w/w) and the hydrophilic colloid providing a water/alcohol- mixture, and iii. mixing the water immiscible phase from step (i) with the water/alcohol-mixture in step (ii) and obtaining the emulsion-type product.
Patent NZ-577945-A (NZ)
Title: Composition of hard deer antler for treating osteoporosis
Inventor: COLLIE DAVID
IPC: A61K35/32
Filed: 2010-09-15
Abstract: Formulations and uses thereof of hard deer antler harvested from deer in the time period after stripping to the time period before casting. The formulations of hard deer antler upon administration to an animal; (a) increases osteoblast cell function; or (b) decreases osteoclast cell function; or (c) increases osteoblast cell function and decreases osteoblast cell function. The hard deer antler is used for the treatment of osteoporosis and/or bone fractures.
Patent NZ-579649-A (NZ)
Title: Hexahydro-cycloheptapyrazole cannabinoid modulators
Inventor: XIA MINGDE
IPC: A01N43/56
Filed: 2008-03-06
Abstract: Disclosed is a compound selected from (8E)-8- (3-fluoro-benzylidene)-1-methyl-1,4,5,6,7,8-hexahydro-cycloheptapyrazole-3-carboxylic acid [(1R)-3-hydroxy-1-phenyl-propyl]-amide, (8E)-8-(3-chloro-benzylidene)-1,4,5,6,7,8-hexahydro-cycloheptapyrazole-3-carboxylic acid [(1R)-3-hydroxy-1-phenyl-propyl]-amide, (8R*)-(3-chloro-benzyl)-1,4,5,6,7,8-hexahydro-cycloheptapyrazole-3-carboxylic acid [(1S)-2-methoxy-1-phenyl-ethyl]-amide, (8S*)-(3-chloro-benzyl)-1,4,5,6,7,8-hexahydro-cycloheptapyrazole-3-carboxylic acid [(1S)-2- methoxy-1-phenyl-ethyl]-amide, (8S*)-(3-chloro-benzyl)-1,4,5,6,7,8-hexahydro-cycloheptapyrazole-3-carboxylic acid [(1R)-2-methoxy-1-phenyl-ethyl]-amide, (8R*)-(3-chloro-benzyl)-1,4,5,6,7,8-hexahydro-cycloheptapyrazole-3-carboxylic acid [(1R)-2-methoxy-1-phenyl-ethyl]-amide, (2E)-8-(3-chloro-benzyl)-1,4,5,6,7,8-hexahydro-cycloheptapyrazol-3-yl]-ethenesulfonic acid piperidin-1-ylamide, 8-(3-chloro-benzyl)-1,4,5,6,7,8-hexahydro-cycloheptapyrazole-3-carboxylic acid 1-phenylethyl-amide, and 8-(3-chloro-benzyl)-1, 4,5,6, 7,8-hexahydro-cycloheptapyrazole-3-carboxylic acid [(1R)-1-phenylethyl]-amide or salt thereof for treating inflammatory bowel disease, intra-abdominal sepsis, acute appendicitis, cholecystitis, pancreatitis or ureteric colic.
Patent NZ-579705-A (NZ)
Title: Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
Inventor: HARIRI ROBERT J
IPC: A61K35/545
Filed: 2003-02-13
Abstract: Provided is a method of differentiating placental stem cells to cardiac cells, comprising placing said placental stem cells under conditions in which the placental stem cells differentiate into said cardiac cells, wherein said differentiating comprises culturing placental stem cells in DMEM/20% FBS comprising 1 uM retinoic acid, 10 ng/ml basic fibroblast growth factor, 2 ng/ml transforming growth factor beta-1, and 100 ng/ml epidermal growth factor; and culturing said cells for 10-14 days to produce said cardiac cells, wherein said cardiac cells express a gene encoding cardiac actin, and with the proviso that the human totipotent cells are not used in the method and that the cells are not inside a human being.
Patent NZ-586837-A (NZ)
Title: Scooter with a mechanism to link it to a child buggy
Inventor: ANDREWS JAMES RICHARD
IPC: B62B7/00
Filed: 2011-07-15
Abstract: A scooter 1 comprising a body made up of a deck chassis 2 having a footrest surface, a handle bar assembly, at least one rear wheel and at least one front wheel each supported by the body and rotatable around an axis, where the deck chassis 2 extends between the front wheel and the rear wheel, and at least one linking member on the scooter 1 that engages a linking mechanism 200 used to releasably attach the scooter 1 to a child buggy 100 thereby linking the scooter 1 to the child buggy 100. The linking mechanism 200 comprises a base section 201 having a first end that engages at least one frame member on the child buggy 100 and a second end that receives at least one scooter linking member. The first end of the base section 201 mates with a fixing section about the at least one frame member of the child buggy 100, and the second end of the base section 201 mates with a plate cover section and which contains there between a plate. The second end of the base section 201, plate cover and plate have at least one aperture there-between into which the scooter link member or members maybe inserted and retained therein.
Patent NZ-587015-A (NZ)
Title: Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
Inventor: BRAJE WILFRIED
IPC: A61K31/4439
Filed: 2008-12-23
Abstract: Disclosed is a compound of formula (I) as depicted where the substituents are as disclosed in the specification. Examples of compounds of formula (I) are 5-Cyano-1-(2,4-dimethoxypheriylsulfonyl)-3-(2-ethoxypyridin-3-yl)-2-oxo-2,3-dihydro-1H-indol-3-yI 4-(4-methylpiperazin-1-yI)benzoate; N-[5-Cyano-3-(2-ethoxypyridin-3-yl)-1-(4-methoxyphenylsulfonyl)-2-oxo-2, 3-dihydro-1H-indol-3-yl]-4-(4-methylpiperazin-1 -yl)benzamide; N-[5-Cyano-3-(2-ethoxypyridin-3-yl)-1-(4-methoxyphenylsulfonyl)-2-oxo-2, 3-dihydro-1H-indol-3-yl]-4-(4-ethylpiperazin-1-yI)benzamide. Also disclosed is a pharmaceutical composition comprising a compound of formula (I) and the use of a compound of formula (I) in the manufacture of a medicament for treatment and/or prophylaxis of vasopressin-dependent diseases such as diabetes, insulin resistance, nocturnal enuresis, incontinence; hypertension, pulmonary hypertension, heart failure, myocardial infarction, coronary spasm, unstable angina; affective disorders; anxiety disorders and stress-dependent anxiety disorders; impairments and Alzheimer's disease; psychoses and psychotic disorders; Cushing's syndrome and other stress-dependent diseases; sleep disorders; depressive disorders; childhood onset mood disorders; symptoms and/or thermoregulatory dysfunctions; drug or pharmaceutical dependencies and schizophrenia.
Patent NZ-589777-A (NZ)
Title: Respiratory syncytial virus renders dendritic cells tolerogenic
Inventor: CONNOLLY JOHN E
IPC: A61K39/00
Filed: 2009-06-05
Abstract: Disclosed is the use of isolated antigen presenting cells that are infected with an effective amount of respiratory syncytial virus (RSV) in the manufacture of a medicament for inducing immune tolerance in a patient afflicted with autoimmune disease, whereby isolated antigen presenting cells are infected with an effective amount of respiratory syncytial virus (RSV) or portions thereof sufficient to infect the antigen presenting cells, and wherein the medicament is used for contacting with CD4+, CD8+ or both CD4+ T cells and CD8+ T cells, wherein the CD4+, CD8+ or both CD4 and CD8+ T cells are rendered tolerogenic as measured in vitro by a mixed leukocyte reaction, wherein the autoimmune disease is insulin-dependent diabetes mellitus, multiple sclerosis, autoimmune encephalomyelitis, rheumatoid arthritis, autoimmune arthritis, myasthenia gravis, thyroiditis, uveoretinitis, Hashimoto's thyroiditis, primary myxoedema, thyrotoxicosis, pernicious anaemia, autoimmune atrophic gastritis, Addison's disease, juvenile diabetes, Goodpasture's syndrome, pemphigus vulgaris, pemphigoid, psoriasis sympathetic ophthalmia, phacogenic uveitis, autoimmune haemolytic anaemia, idiopathic leucopenia, primary biliary cirrhosis, active chronic hepatitis, cryptogenic cirrhosis, ulcerative colitis, Sjogren's syndrome, scleroderma, Wegener's granulomatosis, poly/dermatomyositis, discoid lupus erythematosus or systemic lupus erythematosus
Patent NZ-592075-A (NZ)
Title: Hose coupling for hygenic connection with pins twist locking into sockets
Inventor: HOEFELMAYR TILMAN
IPC: F16L37/107
Filed: 2009-08-28
Abstract: Disclosed is a food grade polyamide hose coupling for providing improved sealing. A food grade hose coupling (100) consists of two coupling parts and an o-ring (100c) that can be located on either coupling part, The first part (100b) has an internal conical sealing surface and a plurality of locking slots or recesses (121b) on the external wall (122b), and a body (110b) for interference fitting inside a hose. The second part (100a) fits inside the internal bore of the first coupling part and has an external conical sealing surface, and matching locking posts or cams(121a) on the external wall (122a) that provide an interference fit within the slots, and a body (110a) for interference fitting inside a hose.
Patent NZ-593797-A (NZ)
Title: Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
Inventor: ALTENBURGER JEAN-MICHEL
IPC: C07D513/04
Filed: 2009-12-24
Abstract: 593797 Disclosed are substituted dihydropyrazolone derivatives of formula (I), wherein the substituents are as described within the specification. An examples of compounds of formula (I) is 2-[5-(piperidin-1-ylsulfonyl)pyridine-2-yl]-1,2,4,5,6,7-hexahydro-3H-indazol-3-one. Further disclosed is a process for preparing a compound of formula (I), a pharmaceutical composition comprising formula (I), and the use of a compound of formula (I) in the manufacture of a medicament for the treatment/prophylaxis of cardiovascular diseases, glaucoma, neurodegenerative diseases, etc.
Patent NZ-606024-A (NZ)
Title: Compact oronasal patient interface
Inventor: KWOK PHILIP RODNEY
IPC: A62B18/08
Filed: 2004-12-24
Abstract: 606024 A breathing arrangement includes a patient interface (10), at least one inlet conduit (22), and a headgear assembly (31). The patient interface (10) includes a mouth covering assembly (14) including a cushion structured to sealingly engage around exterior of a patient’s mouth in use, a nozzle assembly (16) including a pair of nozzles (17) structured to sealingly engage within nasal passages of a patient’s nose in use, and a flexible element (41) connecting the mouth covering assembly (14) and the nozzle assembly (16). The at least one inlet conduit (22) is structured to deliver breathable gas into at least one of the mouth covering assembly (14) and the nozzle assembly (16) for breathing by the patient. The headgear assembly (31) is removably connected to at least one of the mouth covering assembly (14) and the nozzle assembly (16) so as to maintain the mouth covering assembly (14) and the nozzle assembly (16) in a desired position on the patient’s face.
Patent NZ-609926-A (NZ)
Title: Wear part nozzle assembly
Inventor: MORGAN SEAN
IPC: A23C1/04
Filed: 2011-10-28
Abstract: A spray nozzle assembly in particular the type of spray nozzle having a check valve which is specifically adapted to be used with spray drying nozzles for example for the spray drying of milk. The assembly includes at least one wear part made from a hard and abrasion resistant material and a protective housing (120) made from a strong and resilient material. The housing (120) has a downstream chamber adapted to receive one or more of the wear parts in releasably trapped relationship. The downstream chamber has a wall (134) including a post (137) defined by a slot (138) in the downstream chamber wall (134) either side of the post (137), the post (137) including an inwardly extending protuberance (141, 145, 146) at or near its end and adapted to prevent the wear part from escaping from the downstream chamber.